Progressive vascular leukoencephalopathy

I9_PROGVASC

brain aneurysm: A congenital or acquired aneurysm within the cranium.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I67.3 Cause of death: ICD-10 — I67.3 2 out of 7 registries used, show all original rules.	1133
4. Check minimum number of events None	1133
5. Include endpoints None	1133
6. Filter based on genotype QC (FinnGen only)	1133

Control definitions (FinnGen only)

Control exclude: I9_CEREBVASC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: I67
Name in latin: Leucoencephalopathia vascularis progressiva

NAME	I9_PROGVASC
CONTROL_EXCLUDE	I9_CEREBVASC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I673
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I673
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Progressive vascular leukoencephalopathy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8396	4988	3358
Only index persons	7636	4604	3032
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.09
Only index persons	0.15	0.17	0.12
Median age at first event (years)
Whole population	80.45	81.63	78.75
Only index persons	80.80	81.89	79.13

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1133	590	543
Unadjusted period prevalence (%)	0.22	0.20	0.24
Median age at first event (years)	80.01	80.50	79.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
964: Matched controls
9639

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

4503599627370496.0

323.0

963

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

155.8

229.4

236

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

11.7

204.1

437

637

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

97.8

197.3

214

R41.3

ICD-10 Finland

Other amnesia

15.9

132.2

226

182

R4110

NOMESCO Finland

Physiotherapy

5.4

122.0

507

1645

Z2221

NOMESCO Finland

Medical doctor

4.7

104.0

486

1702

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

4.5

89.3

412

1371

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

+∞

85.7

G30.1

ICD-10 Finland

Alzheimer disease with late onset

5.1

74.3

269

674

Z3226

NOMESCO Finland

Physiotherapist

4.2

72.1

337

1089

ZXD10

NOMESCO Finland

Scheduled procedure

3.3

67.4

551

2765

Z3231

NOMESCO Finland

Registered nurse

3.4

65.4

433

1842

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

7.8

63.7

156

232

Z01.9

ICD-10 Finland

Special examination, unspecified

7.5

63.4

160

249

XF400

NOMESCO Finland

ECG with 12 standard connections

3.7

59.2

316

1111

R4120

NOMESCO Finland

Occupational therapy

9.3

58.5

127

154

R53

ICD-10 Finland

Malaise and fatigue

3.3

54.8

363

1494

AA1AD

NOMESCO Finland

CT of head and brain

3.2

54.4

373

1574

Z71.8

ICD-10 Finland

Other specified counselling

3.4

51.5

317

1225

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.6

49.4

122

181

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

5.1

48.2

165

373

XA800

NOMESCO Finland

Neuropsychological investigation

16.6

47.5

ZXE00

NOMESCO Finland

One hour or less

2.7

46.6

488

2638

N06DX01

ATC

memantine; oral

3.6

44.5

231

771

R42

ICD-10 Finland

Dizziness and giddiness

2.8

42.8

360

1679

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

41.2

447

2409

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.1

41.0

266

1041

Z01.7

ICD-10 Finland

Laboratory examination

3.8

40.7

192

587

A28

ICPC

Limited function/disability NOS

2.8

40.5

346

1618

WX002

NOMESCO Finland

Sedation and analgesia

2.9

40.2

305

1322

ZXA05

NOMESCO Finland

Left side

2.6

40.0

401

2058

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

39.9

P20

ICPC

Memory disturbance

2.9

39.8

308

1349

ZXA00

NOMESCO Finland

Right side

2.5

38.3

410

2168

ZXE10

NOMESCO Finland

More than one and less than three hours

2.5

37.6

445

2477

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

8.4

35.8

104

Z76.0

ICD-10 Finland

Issue of repeat prescription

3.4

34.7

189

642

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.4

33.3

183

625

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

64.0

32.2

F03

ICD-10 Finland

Unspecified dementia

4.0

32.2

138

383

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.7

31.3

147

442

C10AA05

ATC

atorvastatin; oral

2.2

31.1

494

3083

F01.9

ICD-10 Finland

Vascular dementia, unspecified

8.9

30.9

M79.6

ICD-10 Finland

Pain in limb

2.3

30.0

395

2245

B01AC04

ATC

clopidogrel; oral

2.6

29.6

253

1144

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.5

29.4

275

1310

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.5

29.4

110

268

N06AX11

ATC

mirtazapine; oral

2.3

28.4

373

2102

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

3.6

28.2

139

433

I10

ICD-10 Finland

Essential (primary) hypertension

2.3

27.5

733

5617

Z73.6

ICD-10 Finland

Limitation of activities due to disability

15.7

27.5

TKC20

NOMESCO Finland

Catheterisation of bladder

3.3

26.5

145

486

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

+∞

26.2

U13

ICPC

Bladder symptom/complaint other

5.3

25.8

167

Z71.9

ICD-10 Finland

Counselling, unspecified

4.3

25.6

101

258

XCK10

NOMESCO Finland

Photography of fundus of eye

2.8

25.6

182

730

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

133.4

24.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.3

24.7

237

SPAT1053

SPAT

Memory test

2.2

23.9

307

1682

ZXD20

NOMESCO Finland

Day surgery

2.8

23.9

170

682

WX892

NOMESCO Finland

Monitored bed care

3.4

23.1

122

399

ZXA10

NOMESCO Finland

Bilateral

2.2

22.9

272

1435

TAB00

NOMESCO Finland

Lumbar puncture

6.0

22.7

113

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

22.1

254

1314

ZXD35

NOMESCO Finland

Usual procedure

4.9

21.8

158

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

224.8

21.7

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

117.6

21.7

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

5.2

21.4

139

Z2446

NOMESCO Finland

Social worker

3.8

21.3

260

R4130

NOMESCO Finland

Speech therapy

8.7

21.3

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

6.6

21.1

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.8

20.9

151

608

N02BE01

ATC

paracetamol; systemic, rectal

2.3

20.5

838

7121

N05AX08

ATC

risperidone; systemic

2.9

20.4

133

502

M54

ICD-10 Finland

Dorsalgia

2.9

19.8

133

509

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

75.1

19.8

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.0

19.6

221

N06DA04

ATC

galantamine; oral

4.4

19.6

172

F01.2

ICD-10 Finland

Subcortical vascular dementia

15.0

19.5

C08CA01

ATC

amlodipine; oral

1.9

19.4

471

3250

M54.5

ICD-10 Finland

Low back pain

2.0

18.9

312

1863

N06DA02

ATC

donepezil; oral

2.6

18.8

150

638

K90

ICPC

Stroke/cerebrovascular accident

12.6

18.7

WX110

SPAT

6.1

18.7

A98

ICPC

Health maint/preventive medicine

2.3

18.2

850

7357

R51.80

ICD-10 Finland

Headache

2.7

18.2

134

544

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

+∞

17.8

C07AB07

ATC

bisoprolol; oral

1.8

17.7

592

4493

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.2

17.4

205

1057

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

17.3

129

527

Z02.7

ICD-10 Finland

Issue of medical certificate

3.1

17.0

334

N30.0

ICD-10 Finland

Acute cystitis

2.2

17.0

189

950

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.5

16.7

248

R41.0

ICD-10 Finland

Disorientation, unspecified

4.0

16.6

180

S01.0

ICD-10 Finland

Open wound of scalp

2.8

16.5

112

433

J01DB01

ATC

cefalexin; oral

1.9

16.4

728

5985

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

2.1

16.4

218

1184

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.9

15.8

183

M25.5

ICD-10 Finland

Pain in joint

2.0

15.8

241

1379

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

61.0

15.8

SPAT1153

SPAT

Removal of sutures

0.5

15.8

129

2370

N06DA03

ATC

rivastigmine; oral, transdermal

2.9

15.8

101

376

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

7.7

15.8

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

15.7

277

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

15.5

247

1436

R5110

SPAT

4.4

15.4

133

F06.7

ICD-10 Finland

Mild cognitive disorder

3.6

15.3

210

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.5

15.1

199

3173

I63

ICD-10 Finland

Cerebral infarction

45.7

15.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

15.0

258

1543

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.3

14.9

137

XF404

NOMESCO Finland

Ambulatory ECG

2.4

14.9

135

612

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

14.9

180

933

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.7

14.7

180

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.7

14.7

180

H81

ICPC

Excessive ear wax

2.0

14.6

231

1337

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

14.6

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

81.3

14.6

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

81.3

14.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

14.5

312

2009

N17

ICPC

Vertigo/dizziness

2.2

14.5

164

827

EB1AA

SPAT

4.3

14.4

128

WX320

NOMESCO Finland

Spinalanesthesy

1.9

14.2

252

1520

R1260

NOMESCO Finland

Evaluation of communicative skills

5.7

14.2

A02BC02

ATC

pantoprazole; systemic

1.7

14.2

629

5029

F05.9

ICD-10 Finland

Delirium, unspecified

4.9

14.1

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.4

14.0

129

588

R60.0

ICD-10 Finland

Localized oedema

2.1

14.0

165

846

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

14.0

197

1089

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

13.9

229

1341

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

20.4

13.8

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.9

13.8

231

1361

N03AG01

ATC

valproic acid; systemic, rectal

3.5

13.8

190

C10AA01

ATC

simvastatin; oral

1.7

13.8

551

4257

Z50.1

ICD-10 Finland

Other physical therapy

2.9

13.6

299

SPAT1263

SPAT

Sampling

0.6

13.6

204

3158

M03BC01

ATC

orphenadrine (citrate); systemic

2.1

13.4

163

847

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

13.4

315

2080

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

5.3

13.3

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

2.1

13.2

159

818

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

13.2

213

1234

R05

ICD-10 Finland

Cough

1.9

13.0

202

1154

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

13.0

210

1217

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

13.0

169

902

N05AH04

ATC

quetiapine; oral

2.2

12.9

141

698

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

14.3

12.8

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

14.3

12.8

WX110

NOMESCO Finland

Local anesthesy

1.6

12.7

538

4182

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

3.1

12.6

248

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.4

12.6

187

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.0

12.6

130

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.6

12.6

166

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

12.5

261

1648

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

24.7

12.5

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

12.3

134

658

Z2445

NOMESCO Finland

Psychologist

6.5

12.2

N30

ICD-10 Finland

Cystitis

2.5

12.2

411

N03AX16

ATC

pregabalin; oral

1.8

12.2

234

1439

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

3.6

12.1

161

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

12.1

360

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.5

12.0

407

WYA30

SPAT

13.6

12.0

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

47.2

11.9

IGY02

NOMESCO Finland

Psychiatric monitoring contact

11.9

U72

ICPC

Urethritis

4.3

11.8

103

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

11.8

151

797

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.6

11.7

372

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

16.6

11.7

G04BD12

ATC

mirabegron; oral

2.1

11.7

148

778

GD1LA

NOMESCO Finland

5.1

11.6

SPAT1312

SPAT

General health counselling

0.5

11.6

119

2068

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

11.5

358

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

11.5

118

567

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

13.8

11.5

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

+∞

11.5

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

+∞

11.5

SPAT1310

SPAT

Counselling related to known health issue

0.5

11.4

132

2218

N06AB04

ATC

citalopram; systemic

1.9

11.4

196

1160

R20.2

ICD-10 Finland

Paraesthesia of skin

3.1

11.3

204

J45

ICD-10 Finland

Asthma

2.4

11.2

436

G44.2

ICD-10 Finland

Tension-type headache

2.2

11.0

114

548

XF606

NOMESCO Finland

Ortostatic test

7.5

11.0

SPAT1301

SPAT

No procedures

0.6

10.9

164

2573

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

10.9

165

930

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

7.9

10.9

XF402

NOMESCO Finland

ECG with work load test

2.0

10.8

140

742

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

10.8

108

512

I50

ICD-10 Finland

Heart failure

2.7

10.8

295

ZXD05

NOMESCO Finland

Urgent procedure

1.7

10.7

302

2073

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

10.7

125

636

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

10.7

127

651

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.4

10.6

151

315

Kela drug reimbursment

Clopidogrel

8.1

10.6

C09CA01

ATC

losartan; oral

1.7

10.6

282

1904

F51.0

ICD-10 Finland

Nonorganic insomnia

2.3

10.6

102

475

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

10.5

164

935

E78

ICD-10 Finland

Disorders of lipoprotein metabolism and other lipidaemias

3.3

10.5

158

I67.4

ICD-10 Finland

Hypertensive encephalopathy

+∞

10.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

10.4

161

913

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.0

10.4

107

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.5

10.4

334

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

10.4

152

847

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

4.3

10.3

N06AB10

ATC

escitalopram; oral

2.0

10.3

138

739

I67.2

ICD-10 Finland

Cerebral atherosclerosis

19.0

10.3

SPAT1097

SPAT

Recording of ECG

0.4

10.3

1186

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

10.2

145

795

S06.0

ICD-10 Finland

Concussion

2.2

10.2

109

533

G30.8

ICD-10 Finland

Other Alzheimer disease

3.2

10.2

173

R06.0

ICD-10 Finland

Dyspnoea

1.7

10.1

288

1976

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

10.1

281

1918

D07AB08

ATC

desonide; topical

2.1

10.0

114

572

M79.1

ICD-10 Finland

Myalgia

2.1

10.0

114

574

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

40.5

10.0

R52.9

ICD-10 Finland

Pain, unspecified

2.3

9.9

396

H53.1

ICD-10 Finland

Subjective visual disturbances

2.8

9.9

246

M15

ICD-10 Finland

Polyarthrosis

2.5

9.8

337

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

6.6

9.8

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

6.2

9.7

H02BX01

ATC

methylprednisolone, combinations; systemic

2.4

9.7

384

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.9

9.7

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

9.6

340

2463

I95.1

ICD-10 Finland

Orthostatic hypotension

2.6

9.6

271

I63.8

ICD-10 Finland

Other cerebral infarction

100.9

9.4

S22.3

ICD-10 Finland

Fracture of rib

2.4

9.4

332

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

9.4

398

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

9.4

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

21.9

9.4

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.9

9.3

191

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.6

9.2

119

-44

ICPC

Preventive immunization/medic

0.3

9.2

633

B01AF02

ATC

apixaban; oral

1.9

9.2

148

851

A98

ICD-10 Finland

Other viral haemorrhagic fevers, not elsewhere classified

4.2

9.1

EBA30

NOMESCO Finland

Excision of root of tooth

2.5

9.1

286

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

8.4

9.1

D11

ICPC

Diarrhoea

2.2

9.1

439

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.4

9.1

318

AXX01

SPAT

4.2

9.0

N03AX14

ATC

levetiracetam; systemic

4.7

9.0

M19

ICD-10 Finland

Other arthrosis

3.5

9.0

117

F00

ICD-10 Finland

Dementia in Alzheimer disease

7.5

9.0

C07AA05

ATC

propranolol; systemic

1.9

8.9

144

827

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

8.9

169

1025

N06AX26

ATC

vortioxetine; oral

3.1

8.9

156

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

8.9

108

557

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

8.7

8.8

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.8

8.8

203

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

8.7

382

2892

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.4

8.7

343

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

8.5

296

2119

S16

ICPC

Bruise/contusion

3.0

8.5

161

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

4.6

8.5

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

90.8

8.4

R55

ICD-10 Finland

Syncope and collapse

1.9

8.4

135

775

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

7.9

8.4

L28

ICPC

Limited function/disability (L)

1.7

8.4

214

1417

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

+∞

8.3

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

+∞

8.3

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

8.3

A02BC05

ATC

esomeprazole; systemic

1.5

8.3

362

2732

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

8.3

371

2816

N06AX21

ATC

duloxetine; oral

2.2

8.3

424

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

8.3

100

517

S20.2

ICD-10 Finland

Contusion of thorax

2.7

8.3

217

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.8

8.2

183

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

14.6

8.2

Z04

ICD-10 Finland

Examination and observation for other reasons

4.2

8.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

8.1

267

1884

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.1

8.1

489

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.2

8.1

L84

ICD-10 Finland

Corns and callosities

3.0

8.1

160

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

8.1

208

1380

F05.1

ICD-10 Finland

Delirium superimposed on dementia

6.4

8.0

J01CA04

ATC

amoxicillin; systemic

1.5

8.0

655

5640

RS222

NOMESCO Finland

4.8

8.0

207

Kela drug reimbursment

Chronic arrhythmias

1.6

8.0

217

1459

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.6

8.0

138

2116

N03AF01

ATC

carbamazepine; oral, rectal

2.6

8.0

224

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

2.1

7.9

461

K59.0

ICD-10 Finland

Constipation

2.2

7.9

375

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

6.2

7.9

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

5.8

7.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.9

7.8

158

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

7.8

435

3450

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

7.8

288

2086

F32

ICD-10 Finland

Depressive episode

3.3

7.8

120

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

7.8

156

961

N05BA01

ATC

diazepam; systemic, rectal

1.8

7.8

131

763

WX212

NOMESCO Finland

Femoral plexus blockade

3.3

7.8

115

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

7.7

413

3242

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.9

7.7

160

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

45.3

7.7

J20

ICD-10 Finland

Acute bronchitis

2.1

7.7

464

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

7.7

441

3516

X58

ICD-10 Finland

Exposure to other specified factors

2.0

7.6

495

N01

ICPC

Headache

2.3

7.6

321

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

7.6

102

547

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

10.1

7.5

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

7.5

119

680

Z01.3

ICD-10 Finland

Examination of blood pressure

4.2

7.5

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

7.5

139

833

G21.8

ICD-10 Finland

Other secondary parkinsonism

13.5

7.4

EBA30

SPAT

13.5

7.4

A23

ICPC

Risk factor NOS

2.7

7.4

190

R51

ICD-10 Finland

Headache

3.0

7.4

146

S00

ICD-10 Finland

Superficial injury of head

8.4

7.3

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

7.3

158

994

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

7.3

359

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

11.0

7.3

G46.7*I67.9

ICD-10 Finland

Other lacunar syndromes

+∞

7.3

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

+∞

7.3

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

+∞

7.3

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

+∞

7.3

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

7.3

104

572

C03CA01

ATC

furosemide; systemic

1.5

7.3

424

3377

G91.0

ICD-10 Finland

Communicating hydrocephalus

15.9

7.2

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

7.2

298

2209

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.2

7.2

111

B01AC07

ATC

dipyridamole; systemic

2.3

7.2

308

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.4

7.2

ZXC20

NOMESCO Finland

Use of chemical agents

2.8

7.2

157

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

7.1

161

1026

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.7

7.1

167

1076

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

7.1

212

1455

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

8.9

7.1

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

7.1

528

Y94.8

ICD-10 Finland

Other leisure activity accident

3.8

7.0

G81.9

ICD-10 Finland

Hemiplegia, unspecified

7.6

6.9

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.9

6.9

143

N05AH03

ATC

olanzapine; systemic

2.9

6.9

143

SPAT1043

SPAT

Audiometry

0.5

6.8

854

XKD00

NOMESCO Finland

Uroflowmetry

1.6

6.8

187

1256

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.2

6.8

292

I11

ICD-10 Finland

Hypertensive heart disease

5.7

6.8

ZY010

NOMESCO Finland

Hospital outpatient

3.4

6.8

SPAT1249

SPAT

Treatment-related counselling outside office

0.7

6.8

199

2733

S00.0

ICD-10 Finland

Superficial injury of scalp

3.3

6.7

G30

ICD-10 Finland

Alzheimer disease

3.4

6.7

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

2.1

6.7

349

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.5

6.6

G04CA02

ATC

tamsulosin; oral

1.5

6.6

270

1986

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

6.6

327

2508

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

6.6

243

1751

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

6.6

137

851

C09DA01

ATC

losartan and diuretics; oral

1.8

6.6

114

670

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

10.1

6.5

R26

ICD-10 Finland

Abnormalities of gait and mobility

10.1

6.5

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

6.9

6.5

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.6

6.5

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.3

6.5

276

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.6

6.5

168

1110

KMAK

NOMESCO Finland

1.4

6.5

344

2670

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.2

6.5

311

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

6.5

446

R11

ICD-10 Finland

Nausea and vomiting

1.9

6.4

492

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.5

6.4

187

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

6.4

163

1075

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

4.4

6.4

M48.0

ICD-10 Finland

Spinal stenosis

1.7

6.4

152

981

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

6.4

315

W19

ICD-10 Finland

Unspecified fall

1.9

6.4

548

C09AA05

ATC

ramipril; oral

1.5

6.3

290

2182

N03AF02

ATC

oxcarbazepine; oral

3.5

6.3

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.1

6.3

320

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

6.3

273

SPAT1336

SPAT

Request for examination

2.5

6.3

201

G25.0

ICD-10 Finland

Essential tremor

3.0

6.3

117

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

4.6

6.3

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.3

318

2442

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

0.6

6.3

116

1763

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

6.3

ZXE22

NOMESCO Finland

Procedure duration at least 4 but less than 5 hours

+∞

6.3

C08CA06

ATC

nimodipine; systemic

+∞

6.3

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

+∞

6.3

R35

ICD-10 Finland

Polyuria

2.0

6.2

378

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

26.8

6.2

J01FF01

ATC

clindamycin; systemic

1.5

6.2

214

1517

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

6.2

126

778

Z01.2

ICD-10 Finland

Dental examination

1.5

6.2

265

1966

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.0

6.2

113

WX290

SPAT

4.5

6.2

R25.1

ICD-10 Finland

Tremor, unspecified

2.8

6.2

136

G04BD08

ATC

solifenacin; oral

1.9

6.2

521

130

Kela drug reimbursment

Malignant tumour

0.4

6.2

569

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

6.2

355

R47.0

ICD-10 Finland

Dysphasia and aphasia

7.7

6.1

S18

ICPC

Laceration/cut

1.4

6.1

384

3069

R07.0

ICD-10 Finland

Pain in throat

2.5

6.1

180

R13

ICD-10 Finland

Dysphagia

2.0

6.1

361

M05BA04

ATC

alendronic acid; oral

1.7

6.1

125

777

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

4.4

6.1

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

6.7

6.0

I84

ICD-10 Finland

Hemorrhoids

2.9

6.0

115

N06AB06

ATC

sertraline; oral

2.0

6.0

365

WX720

NOMESCO Finland

Own respiration

0.0

6.0

150

R31

ICD-10 Finland

Unspecified haematuria

1.7

6.0

121

746

EBA00

SPAT

3.8

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

660

2208

5.76

190.80

3.5

3.1

mmol/l

2.5

0.04

570

1916

(3033658) Prothrombin time (PT) actual/Normal

633

2143

5.43

177.52

4.2

3.8

77.6

82.1

3.97

626

2082

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

559

1796

5.17

164.71

3.3

2.9

e6/l

1.4

1.3

0.23

256

1055

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

539

1686

5.19

164.05

3.4

3.1

e6/l

3.0

2.5

0.48

233

957

(36304419) Bacteria [Presence] in Urine

679

2763

4.64

142.46

4.1

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

691

2919

4.50

136.00

4.1

3.3

e6/l

0.5

0.01

470

2242

(3015377) Calcium [Moles/volume] in Serum or Plasma

752

3594

4.25

119.38

2.8

3.3

mmol/l

2.4

3.20

672

3008

(3018095) Leukocytes [#/volume] in Urine

751

3590

4.24

119.08

5.1

3.9

e6/l

80.5

143.1

1.60

489

2645

(3002582) Erythrocytes [#/volume] in Urine

694

3181

4.05

116.03

4.1

3.4

e6/l

46.1

77.6

1.58

471

2483

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

756

3728

4.09

112.21

4.2

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

849

4582

4.40

109.37

3.2

2.2

pmol/l

90.9

92.6

0.59

449

2304

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

533

2113

3.87

108.90

4.8

4.3

ng/l

187.5

246.8

0.31

515

1881

(3021960) Folate [Moles/volume] in Serum or Plasma

618

2834

3.60

98.51

1.9

1.6

nmol/l

19.1

20.1

1.00

582

2371

(3024561) Albumin [Mass/volume] in Serum or Plasma

812

4525

3.80

93.10

4.0

4.2

g/l

34.7

34.2

1.73

754

4129

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

392

1384

3.80

92.72

2.2

1.7

—

(3003338) MCHC [Mass/volume]

1001

6484

5.67

91.43

37.4

24.5

g/l

328.5

329.9

5.82

990

6406

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

389

1398

3.71

89.11

2.2

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

276

797

4.26

86.25

2.2

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

277

823

4.13

83.00

2.2

u/l

30.6

39.2

1.36

232

688

(3018677) aPTT in Platelet poor plasma by Coagulation assay

362

1315

3.58

80.49

2.0

1.8

30.4

30.1

0.32

355

1258

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

143

253

6.32

79.10

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

143

253

6.32

79.10

1.4

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

487

2148

3.22

78.49

3.5

4.2

—

(3018418) pH of Serum or Plasma

620

3146

3.14

78.16

3.3

3.8

7.4

0.09

584

(3019309) Folate [Moles/volume] in Red Blood Cells

536

2575

3.05

73.22

1.7

1.9

nmol/l

904.4

1193.9

9.70

371

1899

(3000991) Gas panel - Venous blood

271

871

3.78

71.72

4.2

6.0

—

(40758558) Short blood count panel - Blood

472

2160

3.03

69.60

5.2

6.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

278

940

3.59

67.84

3.8

5.1

mmol/l

1.5

1.4

0.80

268

893

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

679

3829

2.93

67.26

2.2

nmol/l

78.6

81.6

1.94

614

3246

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

544

2797

2.82

63.10

2.3

2.0

u/l

286.9

242.1

0.47

510

2573

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

762

4699

2.90

61.48

5.3

5.4

mmol/l

1.2

1.48

716

4169

(3036489) Thrombin time

111

199

6.08

60.22

1.5

2.0

22.3

0.01

104

176

(3013826) Glucose [Moles/volume] in Serum or Plasma

856

5665

3.09

59.63

4.4

mmol/l

6.9

0.23

806

5309

(3002385) Erythrocyte distribution width [Ratio]

932

6546

3.39

56.95

36.1

22.2

14.1

0.06

917

6384

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

416

2010

2.69

52.40

2.2

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1004

7625

3.78

48.76

6.0

4.9

mu/l

1.9

2.3

1.25

952

6690

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

791

5296

2.64

48.72

5.0

6.2

mmol/l

1.2

0.04

734

4408

(3037467) Urinalysis macro (dipstick) panel - Urine

900

6426

2.95

48.71

5.8

5.0

—

(3026782) Osmolality of Urine

429

2185

2.55

47.60

3.0

2.9

mosm/kgh2o

579.2

542.5

2.84

326

1846

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

165

493

3.75

47.46

2.3

3.0

mmol/l

24.0

23.9

0.16

149

442

(3009542) Hematocrit [Volume Fraction] of Blood

953

7063

3.20

47.26

36.7

20.1

38.2

37.0

4.81

804

3987

(3044889) 12 lead EKG panel

874

6203

2.79

46.76

5.0

4.6

—

(3052851) Hemolysis interference index of Serum or Plasma

123

300

4.48

46.68

3.6

—

(3026008) Bacteria identified in Urine by Culture

625

3810

2.43

46.31

4.1

3.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

596

3568

2.41

45.86

2.8

2.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

171

537

3.57

45.58

4.4

7.1

mmol/l

24.2

24.7

1.20

158

486

(3021589) Normoblasts [#/volume] in Blood

606

3738

2.34

42.42

6.9

10.5

e9/l

0.0

0.26

416

3048

(3023368) Bacteria identified in Blood by Culture

546

3232

2.33

41.98

5.5

4.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

120

6.34

41.83

1.2

1.3

e6/l

3.8

77.6

0.92

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

120

6.34

41.83

1.3

1.4

e6/l

55.1

1193.1

0.71

101

(3024891) Influenza virus A+B Ag [Presence] in Specimen

193

5.04

40.84

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

510

2982

2.29

39.78

2.4

2.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1044

8430

4.04

39.62

28.1

18.1

mg/l

29.6

28.3

0.70

930

7025

(3024354) Oxygen [Partial pressure] in Venous blood

232

945

2.83

39.43

2.5

2.6

kpa

4.3

0.01

218

910

(3002032) Base excess in Venous blood by calculation

257

1104

2.72

39.43

2.8

3.0

mmol/l

1.4

2.0

1.81

219

873

(3021447) Carbon dioxide [Partial pressure] in Venous blood

259

1117

2.71

39.43

2.7

3.0

kpa

5.9

5.8

0.23

246

1077

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

239

989

2.80

39.42

2.0

2.4

umol/l

8.5

10.2

0.50

196

845

(3023410) Appearance of Cerebral spinal fluid

10.36

39.12

1.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

934

7104

2.79

39.08

6.5

7.0

u/l

83.0

82.3

0.12

883

6571

(3000850) Epithelial cells [#/volume] in Urine

420

2277

2.34

39.00

2.8

2.7

e6/l

4.9

5.3

0.48

354

1990

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

116

6.17

38.58

1.2

1.3

mmol/l

3.9

0.03

106

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

499

2934

2.25

37.92

2.7

2.3

mg/l

2.8

3.2

3.35

428

2451

(42870588) Differential panel, method unspecified - Blood

505

2985

2.25

37.87

4.4

5.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

410

2251

2.29

36.47

2.2

2.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

108

290

4.01

35.89

2.3

2.5

g/l

0.0

0.00

263

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

108

293

3.97

35.37

2.3

2.5

g/l

0.0

0.00

264

(3013650) Neutrophils [#/volume] in Blood by Automated count

721

5003

2.21

35.20

6.6

7.9

e9/l

4.6

4.4

1.25

554

4286

(40761511) CBC panel - Blood by Automated count

1034

8451

3.56

35.19

20.5

17.9

—

(3044290) Cell count panel - Cerebral spinal fluid

100

6.28

34.81

1.1

1.3

—

(3006315) Basophils [#/volume] in Blood

634

4215

2.14

34.12

5.2

5.0

e9/l

0.0

0.09

466

3538

(3001604) Monocytes [#/volume] in Blood

632

4198

2.14

34.07

5.3

5.0

e9/l

0.7

0.6

1.74

467

3501

(3022096) Basophils/100 leukocytes in Blood

598

3896

2.13

33.84

5.5

5.3

0.6

0.04

550

3557

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

668

4540

2.15

33.82

2.8

2.9

u/l

51.4

57.2

0.80

597

4010

(3001122) Ferritin [Mass/volume] in Serum or Plasma

568

3639

2.12

33.47

3.3

2.8

ug/l

121.2

146.2

1.71

536

3218

(3022217) INR in Platelet poor plasma by Coagulation assay

327

1689

2.32

33.08

41.5

32.0

inr

1.8

1.5

—

213

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

109

312

3.76

33.04

2.3

2.4

g/l

0.1

0.11

280

(3019198) Lymphocytes [#/volume] in Blood

639

4300

2.11

32.83

5.3

5.1

e9/l

1.9

1.8

0.25

479

3676

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

842

6309

2.30

32.77

3.9

pmol/l

14.8

15.3

6.11

766

5498

(3018010) Neutrophils/100 leukocytes in Blood

604

3987

2.10

32.57

5.6

5.3

59.7

59.8

0.05

557

3637

(3006504) Eosinophils/100 leukocytes in Blood

603

3988

2.09

32.24

5.5

5.3

2.7

0.44

555

3632

(3019069) Monocytes/100 leukocytes in Blood

603

4004

2.08

31.70

5.5

9.6

9.1

2.96

554

3660

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

964

7713

2.67

31.59

28.2

17.7

ml/min/173m2

68.4

67.1

1.32

842

6379

(3013115) Eosinophils [#/volume] in Blood

640

4350

2.08

31.51

5.5

5.1

e9/l

0.2

0.24

480

3700

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1042

8729

3.41

30.40

12.0

10.9

u/l

22.0

22.5

0.53

1018

8287

(3002030) Lymphocytes/100 leukocytes in Blood

606

4076

2.05

30.24

5.6

5.5

23.9

24.8

1.00

558

3691

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

988

8051

2.78

30.24

5.7

5.2

mmol/l

2.3

2.5

14.56

916

7043

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

704

5016

2.07

29.75

3.9

5.6

umol/l

12.9

12.5

0.47

659

4720

(3019550) Sodium [Moles/volume] in Serum or Plasma

1051

8883

3.53

29.48

34.2

22.1

mmol/l

139.2

139.4

1.02

1039

8633

(3023103) Potassium [Moles/volume] in Serum or Plasma

1051

8893

3.51

29.21

34.5

22.3

mmol/l

4.0

10.18

1038

8632

(3024731) MCV [Entitic volume]

1056

8979

3.59

28.72

38.6

26.8

92.2

92.0

0.73

1043

8772

(3007461) Platelets [#/volume] in Blood

1056

8979

3.59

28.72

38.6

26.9

e9/l

234.8

237.5

0.64

1028

8669

(3035941) MCH [Entitic mass]

1056

8980

3.59

28.70

38.5

26.7

30.4

0.16

1044

8774

(3026361) Erythrocytes [#/volume] in Blood

1056

8980

3.59

28.70

38.7

26.9

e12/l

4.3

1.25

1029

8627

(3000963) Hemoglobin [Mass/volume] in Blood

1056

8980

3.59

28.70

39.0

27.1

g/l

127.3

129.6

5.31

1044

8771

(3010813) Leukocytes [#/volume] in Blood

1056

8982

3.59

28.64

38.7

26.9

e9/l

7.3

7.0

0.97

1029

8617

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

148

4.75

28.57

1.5

2.4

214.1

214.4

0.01

137

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

226

3.99

28.55

1.1

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

108

340

3.41

28.27

2.4

2.3

g/l

37.0

36.7

0.20

283

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

254

1250

2.33

28.24

4.4

5.3

kpa

5.0

5.1

0.24

240

1170

(42529406) Shigella sp [Presence] in Stool by Culture

228

3.95

28.20

1.1

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

253

1250

2.32

27.83

4.4

5.3

kpa

11.3

11.5

0.29

239

1173

(3012095) Magnesium [Moles/volume] in Serum or Plasma

289

1510

2.23

27.80

2.1

2.7

mmol/l

0.8

0.84

249

1373

(3014765) Yersinia sp identified in Stool by Organism specific culture

227

3.92

27.57

1.1

1.2

—

(3003396) Base excess in Arterial blood by calculation

253

1258

2.30

27.37

4.3

5.3

mmol/l

0.3

1.4

3.23

217

947

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

958

7815

2.46

27.02

7.3

6.8

mmol/mol

42.3

41.5

1.35

903

6986

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

332

1853

2.12

26.88

1.7

1.6

mg/l

1.5

0.00

244

1445

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

156

4.50

26.78

1.5

2.2

88.0

83.4

0.87

146

(3009466) Valproate [Moles/volume] in Serum or Plasma

6.41

26.32

3.3

3.2

umol/l

313.5

336.2

0.41

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

112

378

3.18

26.15

2.1

2.3

u/ml

0.4

0.3

0.23

219

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

980

8130

2.52

25.68

5.1

5.2

mmol/l

6.3

6.1

1.34

894

7095

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

109

367

3.18

25.54

2.3

2.6

g/l

0.7

1.3

0.96

303

(3004716) Salmonella sp identified in Stool by Organism specific culture

255

3.57

24.65

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

310

1753

2.06

23.81

3.1

3.5

ug/l

0.8

0.9

1.15

245

1274

(3013707) Erythrocyte sedimentation rate by Westergren method

826

6484

2.01

23.63

3.9

4.1

mm/h

15.9

16.2

0.19

759

5820

(3024928) Oxygen saturation in Venous blood

213

3.70

22.91

1.8

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

117

437

2.87

22.81

1.4

1.6

1.7

1.6

0.72

348

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

155

689

2.45

21.28

1.5

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

112

426

2.81

21.08

2.3

2.5

g/l

10.2

10.3

0.07

351

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

109

409

2.84

21.04

2.3

2.5

g/l

3.1

3.2

1.01

316

(3021601) Nitrite [Presence] in Urine by Test strip

613

4477

1.80

20.65

6.7

5.9

estimate

0.0

0.00

813

(3019832) Treponema pallidum Ab [Presence] in Serum

153

4.01

20.48

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

117

4.42

19.85

3.1

3.4

—

(3035350) Ketones [Presence] in Urine by Test strip

609

4474

1.78

19.78

4.1

4.3

estimate

0.0

0.00

827

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

6.56

19.72

1.0

ng/l

250.6

325.6

0.86

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

448

2.69

19.62

2.3

2.5

g/l

4.0

3.8

0.35

306

(3009261) Glucose [Presence] in Urine by Test strip

615

4538

1.78

19.61

4.2

4.4

estimate

0.0

0.00

822

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

450

2.68

19.44

2.3

2.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

451

2.67

19.36

2.3

2.4

g/l

7.5

7.6

0.46

317

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

6.43

19.35

1.0

ng/l

34.1

42.8

0.66

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

6.43

19.35

1.0

ng/l

594.2

611.8

0.09

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

267

1539

1.96

18.87

2.4

2.5

19.2

20.7

1.08

254

1277

(3004789) Transferrin [Mass/volume] in Serum or Plasma

278

1625

1.94

18.85

2.2

2.4

g/l

2.2

2.3

1.37

263

1477

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

163

789

2.25

18.29

1.7

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

249

1426

1.96

17.83

1.8

2.4

1.7

1.8

0.31

206

1231

(3022948) Iron [Moles/volume] in Serum or Plasma

292

1770

1.88

17.57

2.3

2.4

umol/l

10.3

11.4

2.23

274

1606

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

101

402

2.66

17.37

1.9

2.5

—

25.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

173

884

2.13

16.89

2.9

3.1

ng/l

90.8

97.4

0.44

145

716

(3016018) Differential panel - Cerebral spinal fluid

6.22

16.44

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

194

3.32

16.34

1.6

2.1

g/l

3.5

3.6

0.22

182

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

217

1223

1.96

16.14

3.0

3.2

ng/l

315.7

272.8

0.85

204

1112

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

125

572

2.33

15.95

4.0

6.0

mmol/l

24.7

24.9

0.18

125

566

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

6.98

15.74

1.1

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

362

2.61

15.15

1.9

2.3

ug/l

883.4

649.2

0.17

341

(3007164) IgA [Mass/volume] in Serum or Plasma

216

1249

1.90

14.78

1.3

1.5

g/l

3.0

2.7

0.68

670

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

906

7761

1.84

14.77

4.1

4.6

mmol/l

4.1

4.4

15.16

817

6816

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

890

7636

1.77

13.76

4.1

4.5

mmol/l

1.4

1.5

9.30

790

6639

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

118

568

2.20

13.30

2.5

2.1

1.1

0.47

118

563

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

863

7369

1.72

13.23

3.6

4.1

mmol/l

1.2

2.03

751

6332

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

118

3.66

13.06

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

178

1005

1.91

12.99

5.0

5.8

g/l

118.4

118.1

0.07

178

964

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

543

4159

1.59

12.85

3.2

4.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

191

1116

1.86

12.51

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

228

2.82

12.42

1.8

1.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

349

2.45

12.27

1.1

1.3

—

43.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1143

0.33

11.68

5.9

4.6

36.7

34.0

0.47

674

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

117

592

2.09

11.60

1.5

1.7

g/l

1.6

1.5

0.44

502

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.09

11.50

1.0

1.1

u/ml

22.4

2.2

—

(3032080) INR in Blood by Coagulation assay

558

4387

1.54

11.21

11.4

12.1

inr

1.6

1.4

0.65

1151

(3000492) Spirometry study

113

580

2.05

10.77

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

352

2515

1.58

10.76

4.3

5.1

23.2

22.1

0.58

156

1388

(1002224) Polysomnography panel

119

3.36

10.75

1.1

—

(4034850)

284

2.48

10.61

13.3

13.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

5.33

10.61

1.1

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

4.87

10.51

1.0

1.1

u/ml

5.5

2.8

0.33

(3023183) Ammonium ion [Moles/volume] in Plasma

154

3.00

10.28

1.6

2.1

umol/l

27.1

33.0

1.11

117

(40761536) Microorganisms panel - Urine sediment

783

0.25

10.22

4.0

4.6

—

(3019225) pH of Specimen

1094

0.37

10.03

5.8

4.6

—

(3042936) Bacteria identified in Isolate by Culture

214

1374

1.69

9.98

1.9

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

6.15

9.94

1.1

1.0

—

(3051651) Icteric interference index of Serum or Plasma

4.36

9.61

3.4

3.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

7.08

9.30

1.1

u/l

0.9

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

334

2424

1.54

9.28

2.4

2.8

umol/l

5256.7

10128.7

1.09

251

1982

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

218

1436

1.64

9.15

1.3

1.2

u/ml

1.9

1.2

0.40

341

(3020630) Protein [Mass/volume] in Serum or Plasma

160

973

1.75

9.04

2.1

2.5

g/l

65.8

65.7

0.08

136

858

(1761868) Lipid panel - Serum or Plasma

118

1997

0.54

9.04

3.4

3.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

148

2338

0.58

8.82

5.8

4.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

412

3152

1.48

8.79

4.7

5.9

ug/l

3.7

5.1

0.42

358

2762

(40768804) Tissue Pathology biopsy report

442

3436

1.47

8.67

2.3

—

(40768797) Stomach Pathology biopsy report

180

1153

1.67

8.39

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

136

808

1.78

8.31

2.3

2.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

6.15

8.19

2.6

1.9

umol/l

51.1

53.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

196

1293

1.62

8.12

4.0

4.4

mmol/l

1.0

1.02

168

1165

(46235355) HIV 1 and 2 tests - Meaningful Use set

103

572

1.88

7.83

1.4

—

(4027681)

5.23

7.46

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

322

2416

1.46

7.33

2.8

2.7

u/l

36.1

35.1

0.11

297

2271

(3029937) Albumin [Presence] in Urine by Test strip

168

2465

0.63

7.20

5.5

4.7

estimate

0.0

0.00

782

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

188

1266

1.58

7.10

2.2

3.6

u/l

241.3

251.3

0.60

161

1176

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.24

6.98

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

196

2.40

6.95

1.6

1.5

—

(3013512) EKG study

226

3091

0.66

6.91

5.4

4.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

109

2.90

6.83

2.8

3.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.05

6.71

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.74

6.70

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

375

1.98

6.63

1.3

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

768

0.40

6.50

2.9

3.9

0.7

0.9

—

236

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.68

6.49

1.1

1.2

—

(3047181) Lactate [Moles/volume] in Blood

341

0.23

6.44

1.9

4.5

mmol/l

1.4

1.3

—

297

(36660697) Celiac disease serology panel - Serum

488

1.85

6.43

1.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

138

895

1.62

6.08

3.8

5.3

mmol/l

12.0

12.4

0.18

126

837

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

478

3943

1.37

6.07

3.1

3.3

ng/l

2711.6

2074.8

1.82

420

3434

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1273

0.54

6.03

9.2

—

(4268621)

4.56

5.99

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

101

1608

0.59

5.97

4.0

4.3

—

(3048689) Calprotectin [Mass/mass] in Stool

116

724

1.67

5.94

2.0

1.8

ug/g

136.8

158.4

0.35

543

(3003327) Ova and parasites identified in Stool by Light microscopy

167

2.38

5.87

1.6

—

(3049717) Cytology report of Urine Cyto stain

460

1.82

5.78

2.1

2.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

322

1.95

5.45

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

514

0.34

5.38

2.5

1.9

—

(3013290) Carbon dioxide [Partial pressure] in Blood

250

0.20

5.35

2.0

4.8

kpa

5.0

—

244

(3027315) Oxygen [Partial pressure] in Blood

251

0.20

5.34

2.0

4.8

kpa

9.9

8.2

—

245

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

100

619

1.68

5.30

2.2

2.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

4.04

5.18

2.2

3.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

186

2521

0.69

5.17

1.7

1.8

pmol/l

457.1

9716436.2

1.06

167

2007

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.97

5.16

1.0

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

270

3419

0.72

5.02

6.2

4.8

—

(4306422)

3.37

4.89

1.2

1.3

—

(3000494) Fungus identified in Specimen by Culture

136

925

1.53

4.88

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

474

0.35

4.86

2.3

1.8

—

(3006270) Folate [Moles/volume] in Blood

107

2.56

4.82

1.1

1.2

nmol/l

298.6

286.2

0.11

(3011648) Oxygen content in Venous blood

2.91

4.78

1.6

1.3

10.6

9.7

0.40

(3044941) Cell count panel - Synovial fluid

151

2.29

4.76

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

268

0.26

4.75

3.7

3.9

mg/l

24.8

30.3

—

182

(3039000) Anion gap in Blood

249

0.24

4.66

1.2

4.7

mmol/l

11.5

11.2

—

222

(3018572) Chloride [Moles/volume] in Blood

249

0.24

4.66

1.2

4.7

mmol/l

104.2

105.0

—

222

(3017143) Hepatitis C virus Ab [Presence] in Serum

492

1.70

4.62

1.5

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

3.24

4.62

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

260

2019

1.37

4.61

1.4

1.6

mmol/l

1.3

0.53

249

1624

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

14.07

4.58

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.00

4.57

1.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.00

4.57

1.1

1.3

—

(3002256) Pathology report gross observation

160

1147

1.46

4.45

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

152

1089

1.46

4.24

1.8

2.5

ug/l

4.5

5.5

0.74

123

894

(3017732) Neutrophils [#/volume] in Blood

523

0.43

4.16

3.3

3.1

e9/l

3.5

4.2

0.85

350

(3003181) Sodium [Moles/volume] in Urine

237

1.94

4.11

1.3

mmol/l

59.2

59.7

0.03

196

(3027456) Digoxin [Moles/volume] in Serum or Plasma

411

1.70

3.99

3.8

3.2

nmol/l

0.7

0.8

0.91

320

(3000570) Elastase.pancreatic [Mass/mass] in Stool

269

1.86

3.97

1.4

ug/g

209.7

273.7

1.40

165

(4094501)

172

2.07

3.88

1.2

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

2.99

3.86

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

139

2.19

3.85

1.4

—

(3021788) Differential panel - Synovial fluid

190

1.98

3.66

1.3

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.45

3.62

1.5

umol/l

34.8

104.0

—

(40768443) Skin Pathology biopsy report

409

1.65

3.55

1.2

—

(3025130) Human papilloma virus identified in Specimen

3.87

3.52

1.4

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.57

3.48

1.0

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

655

1.51

3.44

1.3

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

238

1.84

3.43

1.4

1.6

e6/l

12514.9

18523.2

0.54

162

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

509

1.57

3.41

1.4

—

(3022621) pH of Urine by Test strip

737

0.57

3.37

3.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

551

1.55

3.37

5.0

6.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

233

0.34

3.20

1.1

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.10

3.09

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.10

3.09

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.10

3.09

1.4

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.10

3.09

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.10

3.09

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.10

3.09

1.4

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

386

1.61

3.06

3.0

2.7

pmol/l

4.1

4.3

0.65

323

(3038177) Helicobacter pylori Ab [Presence] in Serum

2.46

3.05

1.8

1.4

—

(3016038) Potassium [Moles/volume] in Urine

2.28

3.04

1.2

1.1

mmol/l

26.2

37.1

2.15

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

150

1140

1.36

3.01

1.3

1.2

iu/ml

39.8

41.8

0.05

358

(3003694) ABO and Rh group [Type] in Blood

236

1920

1.29

2.94

1.2

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

115

841

1.41

2.91

1.3

titre

490.9

545.9

0.15

198

(3004775) Volume in Urine collected for unspecified duration

2.27

2.88

1.5

2.3

475.6

600.7

0.81

(3004809) Band form neutrophils/100 leukocytes in Blood

175

0.28

2.83

4.0

4.1

1.0

1.7

—

127

(3028308) Erythrocytes [#/volume] in Pleural fluid

165

1.90

2.83

1.3

e6/l

9389.2

62787.0

0.85

(3028271) Lactate [Moles/volume] in Capillary blood

188

0.32

2.82

1.8

1.9

mmol/l

1.3

1.7

—

182

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

220

0.36

2.81

1.1

1.5

—

(3020891) Body temperature

461

1.53

2.77

5.4

3.6

—

(3012441) Differential panel - Pleural fluid

146

1.94

2.72

1.3

1.4

—

(3014891) Appearance of Pleural fluid

3.77

2.67

1.1

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

283

1.65

2.61

1.1

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

2.26

2.45

1.2

1.1

—

42.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.10

2.44

1.9

1.5

u/ml

39.5

18.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.27

2.37

1.0

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

100

743

1.38

2.34

1.7

2.0

nmol/l

418.7

385.9

0.76

658

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

184

0.38

2.29

2.4

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.47

2.28

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.35

2.18

1.1

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

4.30

2.15

1.0

2.4

ug/l

14.0

14.9

—

(3008295) Osmolality of Serum or Plasma

116

1.91

2.12

1.2

mosm/kgh2o

269.4

271.4

0.11

(3023199) Leukocytes [#/volume] in Pleural fluid

184

1.70

2.06

1.3

e6/l

1942.6

1428.9

0.24

135

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.19

2.05

1.8

2.1

—

(4212803)

4.02

2.04

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

511

0.62

2.00

2.9

3.7

0.8

0.9

0.50

481

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.76

1.93

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

171

0.41

1.92

1.1

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

517

0.63

1.91

2.9

3.7

1.3

1.5

1.99

488

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

145

1173

1.27

1.91

2.6

3.9

ug/l

3.1

29.3

2.63

117

989

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.66

1.86

1.1

1.4

—

(40768806) Pleura Pathology biopsy report

159

1.72

1.86

1.3

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

385

1.45

1.84

1.9

3.0

u/ml

334.1

6056.8

1.14

322

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

2.14

1.82

1.2

nmol/l

1.2

1.6

0.79

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.06

1.80

1.1

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

192

1.63

1.79

2.6

2.3

—

(3006653) Thiamine [Moles/volume] in Blood

2.45

1.75

1.0

1.1

nmol/l

151.7

130.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

466

1.40

1.74

1.3

1.2

—

(3035285) Chloride [Moles/volume] in Venous blood

195

1.61

1.70

2.6

2.3

mmol/l

107.3

105.3

0.99

190

(3041354) Potassium [Moles/volume] in Venous blood

195

1.61

1.70

2.6

2.3

mmol/l

4.0

4.1

0.50

190

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

150

1.68

1.64

1.7

1.5

iu/l

4.4

5.2

—

(1616796) Gas panel - Central venous blood

250

0.51

1.62

4.4

3.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.58

1.61

1.0

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

206

1.57

1.61

1.3

1.4

g/l

28.0

29.9

0.36

192

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

3.01

1.58

1.0

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.01

1.58

2.0

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

122

1.73

1.55

1.8

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

2.60

1.51

1.4

—

(3045424) Erythrocytes [Presence] in Urine

127

0.39

1.50

1.6

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

130

1073

1.24

1.47

1.7

2.4

e9/l

67.2

66.8

0.05

846

(3047189) Immunofixation for 24 hour Urine

2.23

1.46

1.5

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

3.13

1.44

1.0

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

723

0.73

1.43

2.6

3.2

ml/min/173m2

49.9

55.0

0.68

341

(3015171) Extractable nuclear Ab [Units/volume] in Serum

229

1.50

1.42

1.2

u/ml

0.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

262

1.47

1.42

1.8

2.4

ug/min

46.5

80.6

0.87

151

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

118

1.71

1.42

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

409

0.65

1.40

2.0

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1.86

1.40

1.4

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1.90

1.39

1.0

1.1

u/ml

232.7

345.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

128

1063

1.23

1.38

1.2

u/ml

2.2

14.4

4.99

329

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

223

0.53

1.37

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

104

1.74

1.37

1.4

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

282

1.43

1.35

1.0

1.1

—

163.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

0.00

1.34

0.0

1.3

—

769.3

—

(3012565) Volume of 24 hour Urine

0.00

1.34

0.0

2.7

—

1745.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

0.00

1.34

0.0

1.2

—

21.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

0.00

1.31

0.0

7.0

—

73.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

132

0.45

1.28

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.79

1.28

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

2.79

1.28

1.2

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.05

1.27

1.2

4.9

u/l

227.9

229.9

—

(3034770) Mitochondria Ab [Titer] in Serum

170

1.54

1.26

1.2

1.1

—

656.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

110

909

1.23

1.26

2.0

1.8

g/l

0.2

0.42

828

(3044007) Cell count panel - Peritoneal fluid

2.41

1.24

1.7

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.41

1.24

1.2

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

196

1.49

1.22

1.3

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

409

1.34

1.22

4.4

3.0

mmol/l

1.4

1.5

0.06

402

(3029075) Extractable nuclear Ab panel - Serum

2.64

1.21

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

324

1.37

1.19

3.7

3.2

mmol/l

8.2

7.9

0.24

315

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.31

1.19

2.0

1.2

—

(40768793) Breast Pathology biopsy report

186

0.53

1.17

1.1

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

127

0.47

1.17

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

128

0.47

1.17

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

128

0.47

1.17

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

128

0.47

1.17

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

129

0.46

1.16

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

129

0.46

1.16

1.5

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

2.06

1.15

1.1

1.8

—

34.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1.81

1.15

1.1

1.2

—

126.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.76

1.13

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

139

0.50

1.09

1.0

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

340

1.34

1.06

3.6

3.1

mmol/l

1.7

1.8

0.07

332

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

0.49

1.05

1.2

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

122

0.49

1.05

1.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

0.48

1.04

3.5

4.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

130

1.55

1.03

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

2.18

0.98

1.0

—

0.2

—

(3033799) Differential panel - Peritoneal fluid

2.18

0.98

1.4

1.9

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.98

0.0

2.5

—

(44806420)

1.86

0.96

2.0

2.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.96

0.0

1.5

—

(3022313) Gas panel - Capillary blood

480

0.76

0.86

4.9

3.9

—

(3037121) Protein [Mass/volume] in Urine

378

0.73

0.85

2.7

g/l

0.5

0.3

0.48

126

(3048929) Epstein Barr virus Ab [Presence] in Serum

104

1.55

0.84

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.57

0.84

1.5

1.7

—

(4146454)

111

0.54

0.83

4.2

3.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

213

0.65

0.82

2.9

3.0

u/ml

28.8

1877.3

0.88

195

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.88

0.82

1.2

1.0

—

6.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

392

1.26

0.81

6.6

5.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

520

1.22

0.79

1.8

2.8

g/l

11.4

11.1

0.23

459

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

147

0.61

0.79

1.1

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.00

0.79

0.0

1.3

—

(40762814) Titanium [Mass/volume] in Blood

0.00

0.79

0.0

1.8

—

2.6

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

0.78

0.0

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.00

0.77

0.0

1.1

—

2.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

244

1.32

0.76

1.3

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.09

0.74

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

132

0.60

0.73

2.0

2.4

—

(3000764) Benzodiazepines [Presence] in Urine

2.00

0.72

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

2.00

0.72

1.0

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

2.00

0.72

1.0

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

619

0.82

0.71

5.8

3.8

mmol/l

1.3

2.3

0.89

464

(3027008) Opiates [Presence] in Urine

1.93

0.70

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.93

0.70

1.4

1.2

—

(3016879) Cocaine [Presence] in Urine

1.93

0.70

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.93

0.70

1.0

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

301

1.27

0.70

2.3

1.8

u/l

39.7

38.1

0.20

256

(3019060) Gas panel - Arterial blood

789

1.17

0.70

3.8

3.4

—

(3000330) Specific gravity of Urine by Test strip

668

1.18

0.69

5.3

4.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

136

1.40

0.67

1.4

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.79

0.66

3.2

1.8

nmol/l

12.0

11.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.59

0.65

1.0

1.1

u/l

78.7

421.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

2.5

—

3.2

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

0.00

0.60

0.0

1.6

—

29.8

—

(3020650) Glucose [Presence] in Urine

0.00

0.60

0.0

2.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

388

0.79

0.59

1.6

2.9

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

0.59

0.0

1.1

—

19.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.47

0.58

1.1

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

438

4190

1.07

0.55

4.7

4.4

ng/l

41.2

65.8

1.59

292

3332

(3005570) Glucose [Moles/volume] in Urine

125

0.64

0.54

1.3

2.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.47

0.54

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

304

0.78

0.52

3.9

3.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

397

1.19

0.52

4.0

3.4

mg/l

35.1

227.8

0.73

318

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

397

1.19

0.52

3.9

3.4

mg/l

69.4

77.9

0.07

321

(3044927) Protein electrophoresis panel - Urine

132

0.68

0.52

1.6

1.2

—

(44813793)

1.50

0.51

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.42

0.50

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.47

0.50

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.49

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

145

1.32

0.49

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

107

0.65

0.48

1.3

1.5

—

(3017569) Oxygen content in Arterial blood

1.49

0.47

2.6

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.42

0.47

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.46

0.47

1.0

—

(3024263) Appearance of Synovial fluid

1.43

0.46

1.0

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

431

1.17

0.46

2.3

nmol/l

12.5

11.3

0.38

365

(3020491) Glucose [Moles/volume] in Blood

0.60

0.45

1.4

3.5

mmol/l

7.0

7.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

1.43

0.45

1.9

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

641

1.13

0.43

1.4

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.62

0.43

1.0

1.1

—

(44790048)

0.66

0.42

1.2

1.3

—

(44790047)

0.66

0.42

1.2

1.3

—

(44790049)

0.66

0.42

1.2

1.3

—

(44806118)

0.66

0.42

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.38

0.42

1.1

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

1.38

0.41

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.41

0.0

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.40

0.0

4.6

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.40

0.0

1.0

—

8.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

287

1.19

0.40

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.40

0.0

1.2

—

23.1

—

(3022689) Creatine [Moles/volume] in Urine

0.00

0.40

0.0

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.00

0.39

0.0

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.00

0.39

0.0

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

487

1.14

0.37

1.8

1.7

ug/l

1.0

2.6

1.33

411

(3022145) Colonoscopy Study observation

879

1.10

0.37

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.35

0.37

9.6

5.0

—

(3045142) Bone marrow Pathology biopsy report

116

1.30

0.37

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.27

0.36

1.1

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.34

0.36

1.6

2.2

—

2139.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.63

0.35

1.2

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1.43

0.35

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

109

1.29

0.33

1.1

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

322

1.15

0.33

1.3

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

250

0.84

0.30

2.0

2.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

206

0.82

0.29

1.4

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

326

1.14

0.29

1.1

1.2

iu/ml

218.3

139.4

—

107

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

109

0.73

0.29

1.3

1.2

u/l

14.0

16.9

—

(4010399)

585

1.10

0.28

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.21

0.26

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.67

0.26

1.2

1.8

—

(3025941) Bacteria identified in Stool by Culture

407

1.11

0.24

1.4

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

274

1.14

0.24

1.2

1.7

—

(3014271) Vancomycin [Susceptibility]

0.73

0.24

2.7

2.9

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.21

0.0

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.3

—

5379.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.21

0.0

7.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

7.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.21

0.0

7.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.21

0.0

2.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.21

0.0

1.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

34.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

193

1.14

0.19

1.4

1.5

—

(3035880) pH of Pleural fluid

1.22

0.19

1.0

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.13

0.18

7.8

4.2

—

23.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.13

0.18

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.13

0.18

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1.21

0.18

1.1

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.21

0.18

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

306

3133

0.97

0.17

3.5

3.9

mg/mmol

15.9

9.1

0.83

188

1950

(3035320) C reactive protein [Mass/volume] in Body fluid

0.76

0.17

2.8

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.75

0.17

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

0.75

0.17

1.4

2.0

ug/l

0.9

1.9

—

(3026470) Cobalt [Mass/volume] in Blood

0.72

0.17

1.4

1.9

ug/l

1.9

3.2

—

(3012516) Albumin [Mass/volume] in Urine

300

2935

1.03

0.15

2.7

3.1

mg/l

89.9

317.4

2.42

196

1846

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

178

1.13

0.15

1.1

1.2

—

(3037756) Immunofixation for Serum or Plasma

284

1.09

0.15

1.5

—

(4035726)

809

0.95

0.15

1.3

1.4

—

(3021901) Oxygen saturation in Capillary blood

212

0.89

0.14

5.3

2.7

—

(3008898) HLA-B27 [Presence]

103

1.17

0.13

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.83

0.13

1.5

1.2

nmol/l

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

115

0.87

0.10

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

114

1107

1.03

0.10

2.6

4.0

—

(3019150) Specific gravity of Urine by Refractometry

207

2030

1.02

0.10

5.5

4.8

kg/l

1.0

3.37

338

(3006462) Nitrate [Presence] in Urine

1.06

0.09

4.2

4.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

134

0.89

0.08

1.2

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

107

1.12

0.08

1.8

—

(40768800) Prostate Pathology biopsy report

224

1.07

0.08

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

601

0.96

0.07

2.0

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.86

0.07

1.1

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.87

0.07

1.0

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.85

0.07

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.12

0.07

2.3

1.7

—

(4281824)

0.88

0.06

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

289

2917

0.99

0.05

2.7

3.1

mmol/l

6.5

6.6

0.13

227

2325

(40761535) Cells panel - Urine sediment

895

0.98

0.04

4.0

3.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

142

1.06

0.02

1.1

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

300

2994

1.00

0.00

2.3

u/l

59.8

57.7

0.26

276

2725

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

146

1.03

0.00

1.1

1.2

nmol/l

0.8

0.9

0.05

120

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.02

0.00

1.4

1.2

—

(21494434) Karyotype in Bone marrow

108

1.02

0.00

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

249

1.00

0.00

2.4

2.1

g/l

135.4

125.1

0.90

181

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.03

0.00

1.1

1.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

113

0.97

0.00

2.1

2.8

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

203

0.98

0.00

1.2

1.5

iu/ml

0.1

23.3

—

(4211845)

0.98

0.00

4.2

4.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

4.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

3.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.7

—

11.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.99

0.00

1.0

1.2

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.00

0.0

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.89

0.00

1.0

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.2

—

(3001729) Color of Synovial fluid

0.00

0.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.02

0.00

1.2

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

0.91

0.00

1.1

1.3

e6/l

19874.6

144244.9

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

0.00

0.0

1.8

—

71.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3025315) Body weight

0.00

0.0

5.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.0

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.89

0.00

1.3

1.1

g/l

1.4

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_PROGVASC and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_PROGVASC	1.801 [1.51, 2.14]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.614

During the follow-up period (1.1.1998 — 31.12.2019), 1426 out of 3641 females with I9_PROGVASC died.

Males

Parameter	HR [95% CI]	p-value
I9_PROGVASC	2.237 [1.78, 2.82]	< 0.001
Birth year	0.984 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1110 out of 2445 males with I9_PROGVASC died.

Mortality risk

Mortality risk for people of age

years, who have I9_PROGVASC.

N-year risk	Females	Males
1	0.181%	0.372%
5	1.113%	2.372%
10	2.898%	6.012%
15	5.374%	11.12%
20	9.441%	18.33%

Relationships between endpoints

↥

Index endpoint: I9_PROGVASC – Progressive vascular leukoencephalopathy

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Progressive vascular leukoencephalopathy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints